Ad-TD-nsIL12

BIOLOGICAL2 trials

Sponsors

Capital Medical University

Conditions

Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus

Phase 1

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

RecruitingNCT05717699

Capital Medical UniversityAdverse Drug Event, Diffuse Intrinsic Pontine Glioma, Oncolytic Virus

Start: 2023-01-04End: 2028-01-04Target: 18Updated: 2024-02-28

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

RecruitingNCT05717712

Capital Medical UniversityAdverse Drug Event, Diffuse Intrinsic Pontine Glioma, Oncolytic Virus

Start: 2023-01-04End: 2028-01-04Target: 18Updated: 2024-02-28

Related Papers

The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials

Nature Communications2025-07-285 citations